Mode
Text Size
Log in / Sign up

Efficacy of Levodopa Based Therapy for Motor and Cognitive Recovery After StrokeLevodopa does not improve movement after a stroke

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Levodopa adjunct therapy shows no significant benefit for motor function, mood, or cognition in post-stroke patients.

This meta-analysis evaluated the impact of levodopa-based therapy as an adjunct to standard rehabilitation protocols for adults following a stroke. The study analyzed data from 1,257 patients to determine if dopaminergic intervention could enhance recovery outcomes compared to a placebo.

Results indicated that levodopa did not produce statistically significant improvements in motor function. The analysis showed a negligible effect size (SMD: 0.01) for primary motor outcomes measured by validated scales like the Fugl-Meyer Assessment, suggesting no clinical benefit over placebo.

Secondary outcomes including mood and cognitive function also failed to show significant improvement with levodopa supplementation. These findings suggest that dopaminergic agents do not provide additional benefits for general stroke patients in a standard rehabilitation setting.

Clinicians should note that levodopa-based therapy does not improve motor, cognitive, or mood outcomes during stroke recovery. Consequently, such treatments should not be routinely prescribed unless specifically indicated by unique biomarkers or within targeted mechanistic trials.

How this fits prior evidence

This meta-analysis addresses a gap in determining the efficacy of dopaminergic agents in stroke recovery. While other interventions like HF-rTMS significantly improve memory metrics and non-immersive virtual reality improves upper limb function, this finding confirms that levodopa-based therapy does not provide similar benefits for motor, mood, or cognitive outcomes. It clarifies that levodopa is not a viable substitute for the improvements seen in specialized therapies like HF-rTMS or NIVR.

When someone survives a stroke, the road to recovery is long and often involves trying different therapies to regain movement. One common question for doctors is whether adding levodopa—a medication typically used for Parkinson's disease—can help patients move better during their rehabilitation.

Researchers looked at data from 1,257 adults who had suffered a stroke. They compared those receiving standard rehabilitation with those getting extra levodopa. The results showed that the levodopa did not make a measurable difference in motor function. It also did not improve the patients' mood or their cognitive abilities, which involve things like memory and thinking.

Because levodopa did not show these benefits, experts suggest it should not be used as a routine treatment for stroke recovery. Instead, doctors should focus on standard rehabilitation unless a patient has a specific biological marker that suggests they might respond differently.

What this means for you:
Levodopa does not improve movement, mood, or thinking in adults recovering from a stroke.

Common questions

Does levodopa help with movement after a stroke?

No, the study of 1,257 adults found that adding levodopa to standard rehabilitation did not result in any significant improvement in motor function compared to a placebo. Because it did not show a measurable effect on physical movement, doctors do not recommend using it routinely for stroke recovery.

Can levodopa improve mood or thinking after a stroke?

The research found no significant difference in mood or cognitive function for patients taking levodopa compared to those who did not. Both mood and cognition remained the same regardless of whether the medication was added to the rehabilitation plan.

Should I take levodopa during stroke rehabilitation?

The study suggests that levodopa should not be used routinely for stroke recovery because it did not improve motor, cognitive, or mood outcomes. You should talk to your doctor about the best ways to manage your specific symptoms during rehabilitation.

Study Details

Study typeMeta analysis
Sample sizen = 1,257
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
BackgroundThe dopaminergic system plays a key role in neuroplasticity and motor learning, suggesting that levodopa can enhance recovery after stroke. However, the clinical evidence is inconsistent. This systematic review and meta-analysis aimed to provide a definitive synthesis of randomized controlled trials (RCTs) that evaluated levodopa-based therapy as an adjunct to stroke rehabilitation.MethodsFollowing PRISMA and Cochrane guidelines, we systematically searched PubMed, Embase, and CENTRAL from inception to October 2025 for RCTs comparing levodopa with placebo in adults who had experienced a stroke and were undergoing rehabilitation. The primary outcome was motor recovery, which was assessed using validated scales (eg, Fugl-Meyer Assessment). Secondary outcomes included mood and cognitive function. Pooled standardized mean differences (SMDs) were calculated using a random-effects model with the Hartung-Knapp-Sidik-Jonkman adjustment.ResultsSeven RCTs comprising 1257 participants (mean age, 62-73 years) met the inclusion criteria. Levodopa had no significant effect on motor function compared with placebo (SMD: 0.01; 95% CI: -0.10 to 0.13;  = 0%), mood (SMD: -0.10; 95% CI: -0.30 to 0.10;  = 3%), or cognition (SMD: -0.05; 95% CI: -0.29 to 0.19;  = 0%). Sensitivity analyses confirmed the stability of the results.ConclusionsLevodopa-based therapy does not improve motor, cognitive, or mood outcomes during stroke rehabilitation. These findings close a long-standing question and indicate that dopaminergic augmentation should not be used routinely outside of mechanistic or biomarker-stratified trials.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.